Use of bactericidal/permeability increasing protein or biologica

Details Use of bactericidal/permeability increasing protein or biologica Use of bactericidal/permeability increasing protein or biologica

1990-01-22

1992-02-18

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Extract, body fluid, or cellular material of undetermined...

Blood

514 2, 514 21, 530829, A61K 3514

Patent

active

050892746

ABSTRACT:
The present invention provides a method of inhibiting lipopolysaccharide (LPS)-mediated stimulation of cells. This method comprises contacting the cells, in the presence of a cell-stimulating amount of lipopolysaccharide, with Bactericidal/Permeability Increasing Protein (BPI) in an amount effective to inhibit cell stimulation.

REFERENCES:
Weiss et al., "Purification & Characterization . . . ", J. Biol. Chem. 253(8): 2664-2672, 1978.
Weiss et al., "The Role of Lipopolysaccharides . . . ", J. Immunol. 132(6): 3109-15, 1984.
Weiss et al., "Cellular & Subcellular . . . ", BA83(9): 86173, 1987.
Doi et al., "A 25-KDa NH.sub.2 -Terminal Fragment . . . ", J. Biol. Chem. 262(31): 14891-94, 1987.
Tobias et al., "A Family of . . . ", J. Biol. Chem. 263(27): 13479-81, 1988.
Elsbach et al., "Separation and Purification . . . ", J. Biol. Chem. 254(21): 11000-11009, 1979.
M. N. Marra, et al. (1990) J. Immunol., 144:662-666.
P. Elsbach, et al. (1988) Bacteria-Host Cell Interaction, pp. 47-60.
P. Gray, et al. (1988) Clinical Research, 36(3):620A.
P. Gray, et al. (1989) The Journal of Biological Chemistry 264(16):9505.
J. Weiss, et al. (1982) The American Society of Clinical Investigation, Inc. 69:959.
J. Weiss, et al. (1985) The American Society of Clinical Investigation, Inc. 76:206.
S. Leong, et al. J. Cell Biochem. Suppl. 13:66 (1989).
J. Weiss, et al. Infection and Immunity, 38:1149-1153 (1982).
K. Muello, et al. Clinical Research, 31:371A.
J. Weiss, et al. J. Clin. Invest., 71:540-549 (1983).
W. M. Shafer, et al. Infection and Immunity, 45:29-35 (1984).
C. J. Hovde, et al. Infection and Immunity, 54:142-148 (1986).
J. Weiss, et al. Infection and Immunity, 51:594-599 (1986).
J. K. Spitznagel, et al. J. Immunol., 139:1291-1296 (1987).
M. M. Shafer, et al. Infection and Immunity, 55:1536-1539 (1987).
G. I. Veld, et al. Infection and Immunity, 56:1203-1208 (1988).
M. M. Farley, et al. Infection and Immunity, 56:1589-1592 (1988).
B. A. Mannion et al., J. Immunol. 142:2807-2812 (1989).
J. Weiss, et al. (1985) ASCI Metabolism, 33(2):567(A).
B. A. Mannion et al., J. Clin. Invest. 85:853-860 (1990).
A. H. Pereira, et al., Blood 76:825-834 (1990).
R. R. Schumann, et al. Science 249:1429-1431 (1990).

Affiliated with

Also associated with

Rating

Use of bactericidal/permeability increasing protein or biologica does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bactericidal/permeability increasing protein or biologica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bactericidal/permeability increasing protein or biologica will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1821826